Literature DB >> 8709250

Multivariate analysis of human immunodeficiency virus type 1 neutralization data.

P N Nyambi1, J Nkengasong, P Lewi, K Andries, W Janssens, K Fransen, L Heyndrickx, P Piot, G van der Groen.   

Abstract

We report on the use of spectral map analysis of the inter- and intraclade neutralization data of 14 sera of human immunodeficiency virus type 1 (HIV-1)-infected individuals and 16 primary isolates, representing genetic clades A to H in group M and group O. This multivariate analysis has been used previously to study the interaction between drugs and receptors and between viruses and antiviral compounds. The analysis reveals the existence of neutralization clusters, not correlated with the known genetic clades. The structural factors that have been identified may correlate with the most important neutralization epitopes. Three key primary HIV-1 isolates, which allow discrimination of sera that are likely or unlikely to neutralize primary isolates from most of the genetic clades, were identified. Our method of analysis will facilitate the evaluation as well as the design of suitable HIV-1 vaccines, which induce high-titer interclade cross-neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709250      PMCID: PMC190648          DOI: 10.1128/JVI.70.9.6235-6243.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F.

Authors:  M G Morgado; E C Sabino; E G Shpaer; V Bongertz; L Brigido; M D Guimaraes; E A Castilho; B Galvão-Castro; J I Mullins; R M Hendry
Journal:  AIDS Res Hum Retroviruses       Date:  1994-05       Impact factor: 2.205

2.  Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.

Authors:  J P Moore; M Thali; B A Jameson; F Vignaux; G K Lewis; S W Poon; M Charles; M S Fung; B Sun; P J Durda
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

3.  Presence in India of HIV type 1 similar to North American strains.

Authors:  P V Baskar; S C Ray; R Rao; T C Quinn; J E Hildreth; R C Bollinger
Journal:  AIDS Res Hum Retroviruses       Date:  1994-08       Impact factor: 2.205

4.  Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.

Authors:  J Louwagie; F E McCutchan; M Peeters; T P Brennan; E Sanders-Buell; G A Eddy; G van der Groen; K Fransen; G M Gershy-Damet; R Deleys
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

5.  Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire.

Authors:  W Janssens; L Heyndrickx; Y Van de Peer; A Bouckaert; K Fransen; J Motte; G M Gershy-Damet; M Peeters; P Piot; G van der Groen
Journal:  AIDS       Date:  1994-01       Impact factor: 4.177

6.  Genetic and phylogenetic analysis of env subtypes G and H in central Africa.

Authors:  W Janssens; L Heyndrickx; K Fransen; J Motte; M Peeters; J N Nkengasong; P M Ndumbe; E Delaporte; J L Perret; C Atende
Journal:  AIDS Res Hum Retroviruses       Date:  1994-07       Impact factor: 2.205

7.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals.

Authors:  J N Nkengasong; M Peeters; P Ndumbe; W Janssens; B Willems; K Fransen; M Ngolle; P Piot; G van der Groen
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

9.  Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin.

Authors:  J Louwagie; W Janssens; J Mascola; L Heyndrickx; P Hegerich; G van der Groen; F E McCutchan; D S Burke
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.

Authors:  P L Earl; C C Broder; D Long; S A Lee; J Peterson; S Chakrabarti; R W Doms; B Moss
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  30 in total

1.  Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV.

Authors:  S Zolla-Pazner; M K Gorny; P N Nyambi; T C VanCott; A Nádas
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Authors:  J P Moore; P W Parren; D R Burton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates.

Authors:  F Verrier; S Burda; R Belshe; A M Duliege; J L Excler; M Klein; S Zolla-Pazner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.

Authors:  Feng Gao; Eric A Weaver; Zhongjing Lu; Yingying Li; Hua-Xin Liao; Benjiang Ma; S Munir Alam; Richard M Scearce; Laura L Sutherland; Jae-Sung Yu; Julie M Decker; George M Shaw; David C Montefiori; Bette T Korber; Beatrice H Hahn; Barton F Haynes
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.

Authors:  P N Nyambi; P Lewi; M Peeters; W Janssens; L Heyndrickx; K Fransen; K Andries; M Vanden Haesevelde; J Heeney; P Piot; G van der Groen
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

Authors:  Peter Hraber; Bette T Korber; Alan S Lapedes; Robert T Bailer; Michael S Seaman; Hongmei Gao; Kelli M Greene; Francine McCutchan; Carolyn Williamson; Jerome H Kim; Sodsai Tovanabutra; Beatrice H Hahn; Ronald Swanstrom; Michael M Thomson; Feng Gao; Linda Harris; Elena Giorgi; Nicholas Hengartner; Tanmoy Bhattacharya; John R Mascola; David C Montefiori
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 7.  Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.

Authors:  Julia L Hurwitz; Mattia Bonsignori
Journal:  Viral Immunol       Date:  2018-01-09       Impact factor: 2.257

8.  Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.

Authors:  Amandeep K Dhillon; Helen Donners; Ralph Pantophlet; Welkin E Johnson; Julie M Decker; George M Shaw; Fang-Hua Lee; Douglas D Richman; Robert W Doms; Guido Vanham; Dennis R Burton
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

9.  W-curve alignments for HIV-1 genomic comparisons.

Authors:  Douglas J Cork; Steven Lembark; Sodsai Tovanabutra; Merlin L Robb; Jerome H Kim
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

10.  Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.

Authors:  D Cecilia; V N KewalRamani; J O'Leary; B Volsky; P Nyambi; S Burda; S Xu; D R Littman; S Zolla-Pazner
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.